Graciely Gomes Corrêa

Dr. Graciely Gomes Corrêa

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Trends in Biotechnology
Verified
Journal Article
Closed access
DPDanielle Pedrolli
Danielle Pedrolli
NRNathan V. Ribeiro
Nathan V. Ribeiro
PSPatrick N. Squizato
Patrick N. Squizato
VJVictor N. de Jesus
Victor N. de Jesus
DCDaniel A. Cozetto
Daniel A. Cozetto
MCMarcel O. Cerri
Marcel O. Cerri

1 September 2020 in Metabolic Engineering
Verified
Journal Article
Closed access
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
MLMilca Rachel da Costa Ribeiro Lins
Milca Rachel da Costa Ribeiro Lins
BSBruna Fernandes Silva
Bruna Fernandes Silva
GPGabriela Barbosa de Paiva
Gabriela Barbosa de Paiva
VZVitoria Fernanda Bertolazzi Zocca
Vitoria Fernanda Bertolazzi Zocca
DPDanielle Pedrolli
Danielle Pedrolli

31 October 2021 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
VZVitória Fernanda Bertolazzi Zocca
Vitória Fernanda Bertolazzi Zocca
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
MLMilca Rachel da Costa Ribeiro Lins
Milca Rachel da Costa Ribeiro Lins
VJVictor Nunes de Jesus
Victor Nunes de Jesus
LTLeonardo Ferro Tavares
Leonardo Ferro Tavares
DPDanielle Pedrolli
Danielle Pedrolli
CRISPR has revolutionized the way we engineer genomes. Its simplicity and modularity have enabled the development of a great number of tools to edit genomes and to control gene expression. This powerful technology was first adapted to Bacillus subtilis in 2016 and has been intensely upgraded since then. Many tools have been successfully developed to build a CRISPR toolbox for this Gram-positive model and important industrial chassis. The toolbox includes tools, such as double-strand and single-strand cutting CRISPR for point mutation, gene insertion, and gene deletion up to 38 kb. Moreover, catalytic dead Cas proteins have been used for base editing, as well as for the control of gene expression (CRISPRi and CRISPRa). Many of these tools have been used for multiplex CRISPR with the most successful one targeting up to six loci simultaneously for point mutation. However, tools for efficient multiplex CRISPR for other functionalities are still missing in the toolbox. CRISPR engineering has already resulted in efficient protein and metabolite-producing strains, demonstrating its great potential. In this review, we cover all the important additions made to the B. subtilis CRISPR toolbox since 2016, and strain developments fomented by the technology. Graphical abstract

27 May 2022 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
MLMilca Rachel da Costa Ribeiro Lins
Milca Rachel da Costa Ribeiro Lins
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
LALaura Araujo da Silva Amorim
Laura Araujo da Silva Amorim
RFRafael Augusto Lopes Franco
Rafael Augusto Lopes Franco
NRNathan Vinicius Ribeiro
Nathan Vinicius Ribeiro
DPDanielle Pedrolli
Danielle Pedrolli

Verified
Journal Article
Open access
PDF file
BSBruna F. Silva
Bruna F. Silva
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
VZVitória Fernanda Bertolazzi Zocca
Vitória Fernanda Bertolazzi Zocca
FPFlavio Pereira Picheli
Flavio Pereira Picheli
MLMilca R. C. R. Lins
Milca R. C. R. Lins
DPDanielle Pedrolli
Danielle Pedrolli
Autonomous control of gene expression through engineered quorum-sensing processes is broadly applicable to biosynthetic pathways, including simultaneous control of different genes. It is also a powerful tool for balancing growth and production. We had previously engineered a modular autoinduction device for the control of gene expression in B. subtilis. Now, we expand its functionality to repress gene expression autonomously. The engineered R8 promoter responds to AHL accumulation in the culture medium. In a riboflavin-producing strain, the AHL-Lux complex exerts 5-fold repression on the R8-driven expression of the flavokinase/FAD synthetase gene ribC, resulting in a higher titer of the vitamin. We engineered a strain able to autonomously induce and repress different genes simultaneously, demonstrating the potential of the device for use in metabolic engineering.

14 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMilca Rachel da Costa Ribeiro Lins
Milca Rachel da Costa Ribeiro Lins
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
LALaura Araujo da Silva Amorim
Laura Araujo da Silva Amorim
RFRafael Augusto Lopes Franco
Rafael Augusto Lopes Franco
NRNathan Vinicius Ribeiro
Nathan Vinicius Ribeiro
DPDanielle Pedrolli
Danielle Pedrolli
Bacillus subtilis employs five purine riboswitches for the control of purine de novo synthesis and transport at the transcription level. All of them are formed by a structurally conserved aptamer, and a variable expression platform harboring a rho-independent transcription terminator. In this study, we characterized all five purine riboswitches under the context of active gene expression processes both in vitro and in vivo . We identified transcription pause sites located in the expression platform upstream of the terminator of each riboswitch. Moreover, we defined a correlation between in vitro transcription readthrough and in vivo gene expression. Our in vitro assay demonstrated that the riboswitches operate in the micromolar range of concentration for the cognate metabolite. Our in vivo assay showed the dynamics of control of gene expression by each riboswitch. This study deepens the knowledge of the regulatory mechanism of purine riboswitches.